SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank0
3Y CAGR-33.4%
5Y CAGR-24.9%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-33.4%/yr
Annual compound
5Y CAGR
-24.9%/yr
Recent deceleration
Percentile
P0
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.03 | -67.4% |
| 2024 | 0.11 | +50.1% |
| 2023 | 0.07 | -39.6% |
| 2022 | 0.12 | +11.0% |
| 2021 | 0.10 | -27.0% |
| 2020 | 0.14 | -66.1% |
| 2019 | 0.42 | - |